Kindstar Global (Beijing) Technology
Kindstar Global (Beijing) Technology, Inc. is a Chinese enterprise that specializes in providing advanced clinical testing services, including esoteric diagnostic and laboratory testing, to hospitals across the country, particularly tertiary care facilities. Founded in 2003 and based in Wuhan, the company operates laboratory facilities in key cities such as Beijing, Shanghai, and Wuhan. Kindstar Global is committed to enhancing personalized medicine and specialized clinical services by developing innovative testing technologies and methods. In addition to diagnostic services, the company offers medical research, clinical trial services, and translational medicine studies, catering to the needs of physicians, medical institutions, and pharmaceutical companies. The organization adheres to international standards and guidelines to prioritize patient interests and healthcare provider requirements.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
3 past transactions
Haixi Biotechnology
Corporate Round in 2021
Haixi Biotechnology is a research and development company of medical testing reagents, aiming to provide accurate testing reagents for medical special inspections, and provide complete scientific research reagents and services for biomedical researchers. Haixi is committed to the R&D, production, sales and service of medical diagnostics and biomedical research reagent products.
NeoImmune
Seed Round in 2021
NeoImmune is a technology developer focused on advancing the immune system, specifically through the development of reagents for minimal residual disease (MRD) testing. The company specializes in high-throughput reading and writing of T and B lymphocyte receptor profiles, which are critical for enhancing disease detection and treatment. With a commitment to improving clinical testing and therapeutic applications, NeoImmune aims to innovate the field of immunology. Recently, it secured significant funding to promote its MRD products and further research and development of new clinical solutions.
Tailai Biosciences
Seed Round in 2020
TaiLai Biosciences is a biotechnology company based in Shanghai, China, focused on advancing cancer research through innovative multiomics technology. The company specializes in the development of non-invasive cancer screening and analysis tools, which allow researchers to gain deeper insights into cancer development and facilitate the creation of immune-guided therapies. TaiLai Biosciences offers a range of biopsy products and services that leverage proprietary biomultiomics technology, integrating extensive biological data, including DNA, RNA, proteins, and metabolites. By employing bioinformatics and computational science, the company aims to uncover correlations within this vast information, contributing to improved cancer diagnostics and treatment options.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.